NCT06386809

Brief Summary

Our study aimed to investigate the effects of transcutaneous auricular vagus nerve stimulation (TAVNS) application on treatment efficacy in bruxism in terms of masseter muscle activity, pain, stress level, sleep and life quality, and autonomic functions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 22, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 26, 2024

Completed
5 days until next milestone

Study Start

First participant enrolled

May 1, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

April 26, 2024

Status Verified

April 1, 2024

Enrollment Period

3 months

First QC Date

April 22, 2024

Last Update Submit

April 24, 2024

Conditions

Keywords

bruxismvagusstimulationparasympathetic

Outcome Measures

Primary Outcomes (7)

  • Pain Severity

    Participants' pain intensity will be assessed using the Visual Analog Scale, is a simple, reliable and short-term method commonly used in the clinic to measure pain intensity.The participant is told that the most severe pain he/she experiences is 10, and if he/she has no pain, the pain intensity is 0. The participant will be asked to mark a number between 0 and 10 corresponding to the intensity of pain in the masticatory muscles at rest and during chewing.

    8 weeks

  • Oral Health Quality of Life

    The Oral Health Impact Profile is revised to comprehensively measure the discomfort, disability and handicap related to oral and dental health. The scale consists of 14 questions in 7 dimensions: functional limitation, physical pain, psychological discomfort, physical disability, psychological disability, social disability and handicap. The lowest score that can be obtained from the scale is 0, while the highest score that can be obtained is 56. A high score indicates poor quality of life.

    8 weeks

  • Stress Level

    The Perceived Stress Scale-14 is a self-report scale designed to assess one's perception of the degree to which a particular situation in daily life is considered stressful. It consists of 14 items and is rated on a 4-point Likert scale ('0: never' to '4: very often'). A high total score indicates a high level of perceived stress.

    8 weeks

  • Sleep Quality

    Pittsburgh Sleep Quality Index will be used to assess the sleep quality of the participants. It assesses sleep duration, sleep disturbance, sleep efficiency, subjective sleep quality, sleep medication use, daytime work disturbance and sleep latency and consists of a total of 24 questions. The total score ranges from 0-21, with 5 and above indicating "poor sleep quality".

    8 weeks

  • Pressure Pain Threshold

    In our study, pressure pain threshold measurement of the dominant and non-dominant side masseter muscle before and after activity will be evaluated with Baseline manual algometer (2.5 kg-11 lb).

    8 weeks

  • Muscle Activation Measurement

    In our study, four-channel 'Neurotrac Myoplus Pro 4 EMG Biofeedback' device will be used for superficial EMG measurements. The EMG work-rest mode of the device will be used in the measurement and the masseter muscle activation during contraction and relaxation will be measured by asking the participant to clench his/her teeth 5 times consecutively, 5 seconds contraction time, 5 seconds relaxation time. Neurotrac PC Software program will be used for electromyographic analysis during the measurement.

    8 weeks

  • Measurement of heart rate variability/ Autonomic nervous system evaluation

    All participants included in the study will undergo a 5-minute heart rate variability measurement test with the Polar H10 chest strap device. The data obtained after the measurement will be analyzed with Kubios program. Stress index (cardiovascular system stress), PNS index (parasympathetic nervous system dominance), SNS index (sympathetic nervous system dominance), LF power (sympathetic activity) and HF power (parasympathetic activity) parameters will be recorded in Kubios program.

    8 weeks

Study Arms (2)

TAVNS group

EXPERIMENTAL
Device: TAVNSOther: Exercise program

Exercise group

OTHER
Other: Exercise program

Interventions

TAVNSDEVICE

TAVNS is a recently introduced treatment involving transcutaneous electrical stimulation of the auricular branch of the vagus nerve with VAGUSTIM device.

TAVNS group

Rocabado 6x6 exercises will be applied in our study. Rocabado exercise, which is the most commonly used exercise method in the literature, is a set of exercises for the craniocervical and craniomandibular system.

Exercise groupTAVNS group

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with bruxism between the ages of 18-65,
  • A history of bruxism for at least 6 months,
  • Individuals with masseter muscle pain GAS≥4 at rest and during mastication

You may not qualify if:

  • Masseter botox application in the last 6 months,
  • Regular use of analgesics and anti-inflammatories that affect the OSS,
  • Presence of infection or tumoral structures within intraoral structures,
  • Wearing multiple ear piercings,
  • With TMJ disc displacement and joint degeneration,
  • Musculoskeletal problem with evidence of cervical or TMJ fracture, systemic disease, specific pathologic condition,
  • Any surgical operation related to a cervical or TMJ problem,
  • Less than 6 months of cervical or TMJ-related physiotherapy and rehabilitation services,
  • The one with facial paralysis,
  • Diagnosed psychiatric illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bandırma Onyedi Eylül University

Balıkesir, Turkey (Türkiye)

Location

Related Publications (1)

  • Guzel HC, Turkmen OB, Mutlu EK, Turkmen G, Sakar O, Ormeci GO. Effectiveness of Transcutaneous Auricular Vagus Nerve Stimulation in Bruxism: A Randomised, Controlled, Single-Blind Experimental Trial. J Oral Rehabil. 2026 Feb;53(2):493-504. doi: 10.1111/joor.70096. Epub 2025 Nov 10.

MeSH Terms

Conditions

Bruxism

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic DiseasesHabitsBehavior

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assist. Prof. Dr

Study Record Dates

First Submitted

April 22, 2024

First Posted

April 26, 2024

Study Start

May 1, 2024

Primary Completion

August 1, 2024

Study Completion

November 1, 2024

Last Updated

April 26, 2024

Record last verified: 2024-04

Locations